Breaking News
August 15, 2018 - College students may experience pressures from secondary exposure to opioid abuse
August 15, 2018 - Powerful new microscope reveals inner workings of human cells with unprecedented clarity
August 15, 2018 - Married people who fight nastily more likely to suffer from leaky guts, study suggests
August 15, 2018 - Working Out After Baby – Drugs.com MedNews
August 15, 2018 - Rheumatoid Factor (RF) Test: MedlinePlus Lab Test Information
August 15, 2018 - ADHD linked to an increased risk of injury in children, study finds
August 15, 2018 - UIC researchers receive NIH funding to develop a better way to regenerate bone or tissues
August 15, 2018 - Study reveals how immune cells in the brain influence sexual behavior
August 15, 2018 - Researchers move closer to finding potential soft spot in drug-resistant tuberculosis
August 15, 2018 - Real-time dynamic monitoring of cell’s nucleus for effective cancer screening
August 15, 2018 - Lower rates of Medicare preventive care visits found in racial, ethnic minority older adults
August 15, 2018 - Scientists identify stress hormone as key factor in failure of immune system to inhibit leukemia
August 15, 2018 - Cytoplan introduces three new nutritional supplements
August 15, 2018 - Effective hemorrhage control critical for survival after motorsport accidents
August 15, 2018 - Sygnature Discovery announces ambitious expansion plan with addition of Alderley Park facility
August 15, 2018 - Dietary carbohydrates could lead to osteoarthritis, new study finds
August 15, 2018 - Male tobacco smokers have decreased number of cannabinoid CB1 receptors, study reveals
August 15, 2018 - Scientists explore ways for drug therapies to reach deadly brain tumors
August 15, 2018 - Rethinking fundamental rule of stroke care: ‘Time is brain!’
August 15, 2018 - Scientists reveal role of ‘junk DNA’ in cancer dissemination
August 15, 2018 - Google’s DeepMind AI could soon be diagnosing eye conditions
August 15, 2018 - Scientists trick the brain to embody the prosthetic limb
August 15, 2018 - Researchers focus on uncoupling obesity from diabetes
August 15, 2018 - A class of proteins shown to be effective in reducing drug-seeking behaviors
August 15, 2018 - FundamentalVR launches first-of-its-kind SaaS software platform for surgical simulation
August 15, 2018 - Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
August 15, 2018 - Rheumatoid arthritis in pregnancy associated with low birth weight and premature birth
August 15, 2018 - Study may help increase effectiveness of antibiotics against drug-resistant bacteria
August 15, 2018 - Analyzing resident-to-resident incidents in dementia may hold the key to reducing future fatalities
August 15, 2018 - Robotic walking frame aims to help maintain mobility of older adults
August 15, 2018 - Simple intervention during routine care reduces alcohol consumption in men with HIV
August 15, 2018 - Genetics Home Reference: gout
August 15, 2018 - Scientists ID genesis of disease, focus efforts on shape-shifting tau
August 15, 2018 - OncoThira and NDSU enter into license agreement to develop, market cancer compounds
August 15, 2018 - Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma
August 15, 2018 - Common signs that indicate vision problems in children
August 15, 2018 - Removing the cancer label – overhaul in cancer classification proposed
August 15, 2018 - Prams may expose babies and toddlers to more air pollution finds study
August 15, 2018 - Duke researchers track missing T-cells in glioblastoma patients
August 15, 2018 - Cardiac Profiles Up With Exercise, Less Sitting in Early Old Age
August 15, 2018 - Precision medicine offers a glimmer of hope for Alzheimer’s disease
August 15, 2018 - Immunovia’s new blood-based testing platform accurately detects non-small cell lung cancer
August 15, 2018 - New method provides a ‘big picture’ of genetic influences on traits and diseases
August 15, 2018 - Early Onset Type 1 Diabetes Linked to Heart Disease, Shorter Life
August 14, 2018 - SMURF1 provides targeted approach to preventing cocaine addiction relapse
August 14, 2018 - Genetic testing pushed for hereditary high cholesterol disease
August 14, 2018 - Researchers discover new genes involved in Alzheimer’s Disease
August 14, 2018 - Medicare to overhaul ACOs but critics fear fewer participants
August 14, 2018 - Adolescent health projects receive meager percentage of global funding, study finds
August 14, 2018 - University Hospitals Seidman Cancer Center launches new CAR-T therapy trial
August 14, 2018 - In the addiction battle, is forced rehab the solution?
August 14, 2018 - Busting myths about milk – Scope
August 14, 2018 - Platelet-rich plasma does not enhance cartilage formation capabilities of stem cells
August 14, 2018 - Wearable devices and ‘mhealth’ technology emerge as promising tools for better health
August 14, 2018 - Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines
August 14, 2018 - Clinical study suggests new treatment direction for head and neck cancer in heavy smokers
August 14, 2018 - Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved Gut Microbiome of Patients with CDI
August 14, 2018 - Cardiac progenitor cells undergo a cell fate switch to build coronary arteries
August 14, 2018 - Study identifies potential guidance to treat gastric cancer patients
August 14, 2018 - Revealed: The molecular mechanism underlying hypertrophic cardiomyopathy, or “workaholic heart”
August 14, 2018 - Diabetes epidemic in Guatemala driven by aging, not obesity
August 14, 2018 - New technology shows potential to streamline the analysis of proteins
August 14, 2018 - Rethinking the stroke rule ‘time is brain’
August 14, 2018 - Incidence of coronary artery compression in children may be more common than previously thought
August 14, 2018 - Study helps to better understand disease caused by Alpha-1 antitrypsin deficiency
August 14, 2018 - AI platform identifies acute neurological illnesses faster than human diagnosis
August 14, 2018 - American College of Rheumatology receives grants to support development of lupus clinical trials
August 14, 2018 - New study explains why women get more migraines than men
August 14, 2018 - American Heart Association Urges Screen Time Limits for Youth
August 14, 2018 - Brief interventions during routine care reduce alcohol use among men with HIV
August 14, 2018 - New genome analysis could identify people at higher risk of common deadly diseases
August 14, 2018 - NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease
August 14, 2018 - Daicel supplies free nanodiamond samples to international researchers
August 14, 2018 - Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes
August 14, 2018 - Study to examine whether modulating gut bacteria can improve cardiac function in heart failure patients
August 14, 2018 - AI technology could hold key to improving health services
August 14, 2018 - One out of two children not getting enough nutrients needed for their health
August 14, 2018 - Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs
August 14, 2018 - Aid-in-dying patient chooses his last day
August 14, 2018 - Exercise Really Can Chase Away the Blues, to a Point
Promoting precision medicine using data science of large datasets

Promoting precision medicine using data science of large datasets

image_pdfDownload PDFimage_print

An interview with Dr. Rajat Mukherjee conducted by Alina Shrourou, BSc

Please give an overview of what exactly data science is, and why it’s important to promote precision medicine.

I feel that data science is a marriage between statistical science and informatics, using statistical principals of math and logic on huge volumes of data.

© Jirsak/Shutterstock.com

You have to rely on informatics to store, read, and then apply these complex statistical algorithms to make sense of huge volumes of information.

A good use of data science can lead to major breakthroughs in medical research in areas like diagnostics, precision medicine, and real-world evidence. By taking large datasets, we can study if different approaches can have a markedly different effect for different patient populations.

What are the benefits of big data analysis compared to traditional collection and analysis?

That’s a good question. In traditional collection and analysis, or randomized clinical trials, the data are often collected in very controlled environments. Things like environmental factors may be very well controlled. On the other hand, factors like genomics may not be accounted for.

© Mopic/Shutterstock.com

Nowadays, real-world data studies or even randomized clinical trials are being designed differently to accommodate the variability and heterogeneity that environmental factors and genetic factors can bring. Data science provides a platform for systematically studying the interaction with environmental factors and genetic factors and looking at the therapeutic effects.

Please outline how you and your research team use data to inform diagnostics? What other biomedical applications are there of data science?

We study biomedical signals and images to develop statistical classifiers that can be used for diagnostics. We also work in the area of precision medicine, researching either genetics or related areas and biomarkers that can help enrich populations for targeted therapeutics. This is becoming more and more popular and important with applications in oncology, rare diseases and difficult to study diseases like Alzheimer’s and Parkinson’s disease.

Another area where data science is useful is in monitoring the patient population for both minor or harmful side effects of therapeutics that are in the market, as many side effects may only become known in the long-term, which can be hard to capture in short term clinical trials.

How can biomedical signals be used as a source of data for diagnosis? Please describe how signal data is processed and transformed to help with data analytics.

Biomedical signals are high-dimensional data, and they need a lot of what we call pre-processing. Essentially, it is the process of filtering out the noise and extracting the valuable information from these signals.

The next step would be feature extraction. We use these methods because you cannot use each and every component of the high dimensional data. You must extract features from these signals and images that are informative of disease status.

Next follows feature selection, i.e. select extracted features or their combinations that have the highest association with disease status. A diagnostic classifier can then be developed and validated using an independent test or validation set. The validation set must be independent of the data set used to develop the classifier.  In general, the diagnostic development and validation using signals and images are done in two separate clinical trials. However, our team works on different seamless options that may lead to much more efficient but still statistically valid designs.

We have been involved in a few diagnostics projects where we have taken biomedical signals and images and transformed them into classifiers. In one of the biggest projects where we have a classifier now, the pivotal validation studies are ongoing. The design of the pivotal validation trial is an operationally seamless, threshold optimization, group-sequential adaptive design which has been accepted by the CDRH, FDA.

How can data science be used to inform biomarker identification and selection? What work is Cytel doing in this area?

Biomarkers are another interesting example, as they play a key role in providing precision medicine strategies. Biomarkers can be diagnostic, prognostic or predictive. Predictive biomarkers help in enrichment strategies for therapies that may only work for a particular sub-population that may be classified as biomarker-positive sub-population.

Biomarker development relies heavily on data science techniques such as filtering and reduction of data and using machine learning techniques to classify patients into biomarker positive/negative.

Please can you also describe data mining work that you are conducting, and how it can inform decision making?

We have yet to use data mining on big data, but we will in the future. However, we have used data mining to look at go/ no-go type decisions, for example, if there have been multiple early phase studies on a particular area or therapeutic, we can pull all of this early phase data together and we do some data mining to come up with these go no-go decisions either to further the pipeline or to call it to an end.

Another new area of interest for us where we have used data mining techniques is the area of pharmacovigilance where large amounts of post-marketing data are used to generate signals for adverse events.

How important are Bayesian models within data science?

As a statistician, when you talk about real world data, I automatically think about Bayesian methods which are ideally suited to apply on accumulating data and updating the information of interest.

Bayesian methods can also be used for automatic feature extraction and selection. These areas suffer from the absence of uniform methodology and Bayesian methods can fill up that gap.

Do you think data science will change the way we manage large volumes of data? What does the future hold for data science and the healthcare and drug discovery industry?

Managing large volumes of data is part of data science, so yes, data science has an integral role to play in the way we manage large volumes of data. Data science will mean having specialized people to take care of big data in the right way, so that it can be applied in real time. Data science is going to change the nature of how big volumes of data are to be stored, accessed and applied.

I think incorporating data science in a drug-development team opens doors to having effective multidisciplinary teams attacking a common problem from different directions.  

Where can readers find more information?

About Rajat Mukherjee

Rajat Mukherjee has 15 years of professional experience as an industry and academic statistician, and brings a range of expert knowledge to Cytel’s customers. This includes work in pattern recognition problems for devices and biomarker discovery, Bayesian clinical trials, adaptive designs, and design and analysis of complex epidemiological studies.

His experience and expertise also includes statistical computing, survival analysis, longitudinal analysis, nonparametric and semiparametric inference, as well as statistical classification and high-dimensional data. Rajat has a strong background and interest in development and implementation of statistical methodology to real life medical problems.

Tagged with:

About author

Related Articles